Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-27T23:14:01.353Z Has data issue: false hasContentIssue false
  • English
  • Français

The Cost-effectiveness of Breast Cancer Screening

Published online by Cambridge University Press:  10 March 2009

Petr Skrabanek
Petr Skrabanek
Affiliation:
University of Dublin
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
International Journal of Technology Assessment in Health Care , Volume 7 , Issue 4 , Fall 1991 , pp. 633 - 635
Copyright
Copyright © Cambridge University Press 1991

References

1.Ranstam, J. On the validity of case-control studies in the evaluation of screening projects. Presented at Nordisk Cancer-union Breast Cancer Symposium, Lidingä, Norway, 08 17–19, 1989.Google Scholar
2.Roberts, M. M.Breast screening: Time for a rethink. British Medical Journal, 1989, 299, 1153–55.CrossRefGoogle ScholarPubMed
3.Schmidt, J.The epidemiology of mass breast screening — A plea for a valid measure of benefit. Journal of Clinical Epidemiology, 1990, 43, 215–25.CrossRefGoogle ScholarPubMed
4.Skrabanek, P.Benefits of mass breast screening rest on equivocal evidence. Diagnostic Imaging International, 1988, 4(3), 29–34.Google Scholar
5.Skrabanek, P.Mass mammography: The time for reappraisal. International Journal of Technology Assessment in Health Care, 1989, 5, 423–30.CrossRefGoogle ScholarPubMed
6.Spratt, J. S., & Spratt, S. W.Medical and legal implications of screening and follow-up procedures for breast cancer. Cancer, 1990, 66, 1351–62.3.0.CO;2-E>CrossRefGoogle ScholarPubMed